DIA 2021 set to shed some light on decentralized trials process, accelerated approval pathways

DIA 2021 set to shed some light on decentralized trials process, accelerated approval pathways

Source: 
Biopharma Reporter
snippet: 

Decentralized trials and remote monitoring, long discussed, but never really taking off until COVID-19 disrupted studies last year, will be under the spotlight at the DIA 2021 Annual Meeting at the end of this month.